FIELD: medicine; biotechnology.
SUBSTANCE: invention relates to compounds having the structural formula (I): , or a salt or solvate thereof; where A1 and A2 independently are oxygen; R1 is selected from the group consisting of hydrogen, NH2; R2 is selected from the group consisting of: , , R3, R5, R6 and R9 independently represent R7th; R4 is selected from the group consisting of C1–4haloalkyl, -(CHR)nC(OH)(CF3)2, -C(O)OR11, -SO2NHC(=O)CH3, -SO2NH2,
, , ; R7 is hydrogen; R11 is independently selected from the group consisting of hydrogen, C1–2alkyl or (CH2)2N(CH3)2; and n is 0; compounds having the structural formula (II): , where X is N or CH; R4 is selected from the group consisting of -C(O)OR11, -C(CF3)(CF3)OH, -(CHR)nC(OH)(CF3)2,
, , ; R11 is selected from the group consisting of hydrogen, C1–2alkyl or (CH2)2N(CH3)2; and n is 0; pharmaceutical compositions, containing them and to the use of such compounds in the treatment and/or prevention of certain types of cancer, pain, inflammation, restenosis, atherosclerosis, psoriasis, thrombosis, Alzheimer's disease, or dysfunction associated with dysmyelination or demyelination.
EFFECT: use of such compounds in the treatment and/or prevention of certain types of cancer, pain, inflammation, restenosis, atherosclerosis, psoriasis, thrombosis, Alzheimer's disease, or dysfunction associated with dysmyelination or demyelination.
20 cl, 4 tbl
Title | Year | Author | Number |
---|---|---|---|
PROTEIN TYROSINE KINASE RECEPTOR INHIBITOR COMPOSITIONS | 2009 |
|
RU2586212C2 |
PYRAZINO[1,2-A]INDOLE COMPOUNDS, PREPARATION AND USE THEREOF IN MEDICAMENTS | 2014 |
|
RU2660417C2 |
METHODS AND COMPOSITIONS WITH APPLICATION OF IMMUNOMODELLING COMPOUNDS IN COMBINED TREATMENT | 2007 |
|
RU2426542C2 |
SUBSTITUTED AROMATIC DERIVATIVE WITH CONDENSED RINGS AND COMPOSITION INCLUDING IT AND THEIR USE | 2020 |
|
RU2811484C1 |
USE OF IBAT INHIBITOR FOR TREATING AND PREVENTING CONSTIPATION | 2008 |
|
RU2482850C2 |
COMPOSITIONS AND METHODS OF TREATING DISEASES AND CONDITIONS | 2015 |
|
RU2713886C2 |
IBAT ANTIOXIDANT APPLICATION FOR TREATMENT OR PREVENTION OF COPROSTASIA | 2004 |
|
RU2342928C2 |
1,5-BENZOTHIAZEPINES AND EMPLOYMENT THEREOF AS ANTIHYPERLIPIDEMIC DRUGS | 2001 |
|
RU2302414C2 |
HETEROCYCLIC COMPOUNDS AS TRK INHIBITORS | 2019 |
|
RU2803817C2 |
2-AMINO-PYRIMIDINE DERIVATIVES AS JNK INHIBITORS | 2011 |
|
RU2572247C2 |
Authors
Dates
2018-06-28—Published
2015-02-05—Filed